Discovery Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$316M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$183M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$182M |
| 4 |
Pfizer
PFE
|
+$164M |
| 5 |
Morgan Stanley
MS
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$540M |
| 2 |
Apple
AAPL
|
+$246M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$231M |
| 4 |
Biogen
BIIB
|
+$204M |
| 5 |
Amazon
AMZN
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.44% |
| 2 | Healthcare | 15.04% |
| 3 | Financials | 11.95% |
| 4 | Communication Services | 10.61% |
| 5 | Technology | 7.19% |
Similar funds
Discovery Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Discovery Capital Management held 146 positions worth $8.44B, down 6.2% from $8.99B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Discovery Capital Management withdrew a net $1.39B in Q4 2015, closing 55 positions and reducing 28 holdings. Its most notable exit was Allergan plc, an estimated $540M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Discovery Capital Management opened a new position in Teva Pharmaceuticals worth $194M.
- Discovery Capital Management's largest Q4 2015 buy was Teva Pharmaceuticals: 2,958,200 shares worth $194M.
- Discovery Capital Management added most to Alibaba in Q4 2015, an estimated $316M increase.
- Discovery Capital Management's biggest Q4 2015 reduction was Amazon, cutting an estimated $191M.
- Discovery Capital Management fully exited Allergan plc in Q4 2015, selling an estimated $540M.
- Discovery Capital Management's ten largest holdings make up 41% of its $8.44B portfolio in Q4 2015.
- Discovery Capital Management opened 35 new positions and closed 55 in Q4 2015.
- Discovery Capital Management's portfolio value fell 6.2% quarter-over-quarter to $8.44B.
Based on Discovery Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.